| Authors: |
Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Division of Dermatology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA., Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA., Siegfried EC; Department of Dermatology and Pediatrics, Saint Louis University School of Medicine, St. Louis, MO, USA.; Department of Pediatric Dermatology, Cardinal Glennon Children's Hospital, St. Louis, MO, USA., Cork MJ; Sheffield Children's NIHR Commercial Research Delivery Centre, Sheffield, UK.; Sheffield Dermatology Research, Division of Clinical Medicine, University of Sheffield Medical School, Sheffield, UK., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Pinter A; Department of Dermatology, University Hospital Frankfurt, Frankfurt am Main, Germany., Deleuran M; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Surrey, BC, Canada.; Probity Medical Research, Waterloo, ON, Canada., Ma Y; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Dubost-Brama A; Sanofi, Gentilly, France., Nguyen TV; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. tien.nguyen2@regeneron.com. |
